Works matching IS 00126667 AND DT 2024 AND VI 84 AND IP 8
Results: 11
Correction: Tegileridine: First Approval.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Tunlametinib: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 8, p. 1005, doi. 10.1007/s40265-024-02072-x
- By:
- Publication type:
- Article
Tarlatamab: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 8, p. 995, doi. 10.1007/s40265-024-02070-z
- By:
- Publication type:
- Article
Tovorafenib: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 8, p. 985, doi. 10.1007/s40265-024-02069-6
- By:
- Publication type:
- Article
Paracetamol Combination Therapy for Back Pain and Osteoarthritis: A Systematic Review and Meta-Analyses.
- Published in:
- Drugs, 2024, v. 84, n. 8, p. 953, doi. 10.1007/s40265-024-02065-w
- By:
- Publication type:
- Article
New and Evolving Treatments for Neurologic Dysphagia.
- Published in:
- Drugs, 2024, v. 84, n. 8, p. 909, doi. 10.1007/s40265-024-02064-x
- By:
- Publication type:
- Article
Mavorixafor: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 8, p. 969, doi. 10.1007/s40265-024-02063-y
- By:
- Publication type:
- Article
Prevention of Rheumatoid Arthritis in At-Risk Individuals: Current Status and Future Prospects.
- Published in:
- Drugs, 2024, v. 84, n. 8, p. 895, doi. 10.1007/s40265-024-02061-0
- By:
- Publication type:
- Article
Biologics or Janus Kinase Inhibitors in Rheumatoid Arthritis Patients Who are Insufficient Responders to Conventional Anti-Rheumatic Drugs.
- Published in:
- Drugs, 2024, v. 84, n. 8, p. 877, doi. 10.1007/s40265-024-02059-8
- By:
- Publication type:
- Article
Zolbetuximab: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 8, p. 977, doi. 10.1007/s40265-024-02056-x
- By:
- Publication type:
- Article
Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity.
- Published in:
- Drugs, 2024, v. 84, n. 8, p. 933, doi. 10.1007/s40265-024-02029-0
- By:
- Publication type:
- Article